Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
AACR, acquireor, Africa, aggressive, ameliorate, Anderson, anemic, Antonio, appellate, appoint, arm, ASH, authorised, backsolving, BET, bidding, biomedical, blinded, bore, bulk, campaign, cheaper, clarity, closer, Commerce, Constant, Constellation, correctly, crossover, CRs, danazol, delineate, disapprove, dissolution, Dr, durable, entitled, erythropoietin, ESMO, esophageal, exert, expiry, extraterritorial, FASBASU, faster, fulfilled, fundamental, Gibraltar, group, havea, highlighting, home, ICO, Inrebic, involuntary, issuedto, IVMDR, jeopardized, Justice, leaseand, left, logistical, madea, MD, meaningfully, mechanism, merger, Mesa, MOMENTUM, NCCN, noteworthy, ona, organizational, Orlando, outbreak, overwhelmed, PACIFICA, PDCO, perception, petition, placebo, platelet, polymorph, prespecified, pro, proportionately, PRs, qualification, questionnaire, RACE, rata, RECIST, reclassification, region, regional, rejected, reluctance, repaid, representation, revaluation, revalued, ROU, Ruben, SD, seemingly, SeeNote, settle, settled, Shield, SPC, splenectomy, splenomegaly, Stable, successfullyobtain, survey, thisForm, timetable, toany, toseek, Transitionally, transposed, TSS, unblinding, unclear, unsolicited, UT, vendor, week, welfare, winding
Removed:
accommodate, ACS, adaptive, ASU, ASUNo, ATM, began, behavior, bioavailability, broadening, cisplatin, CMS, comparison, Composite, conference, coordinated, core, declare, designing, diagnosed, die, discrete, double, ending, engendering, enhanced, entry, evolved, exploit, exploring, expressly, FileNo, flexibility, focusing, generation, genetically, graph, harboring, heel, heightened, Importantly, index, innovative, intravenously, kill, leading, lethal, lethality, leverage, likened, localized, machinery, MTD, mutation, mutational, MYC, necessity, North, opportunistically, ovarian, oxygen, pancreatic, persistent, pharmacological, Plymouth, polymerase, RAS, reactive, render, renegotiated, resistance, resolve, retained, robustly, spread, strand, striking, surgery, synergy, synthetic, synthetically, systemic, turnover, underway, wave
Filing tables
Filing exhibits
Related press release
Associated SRRA transcripts
SRRA similar filings
Filing view
External links
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos.333-205693,333-209897,333-216392,333-223253,333-228263, and333-229933 on FormS-8, and Registration Statement Nos.333-225650 and333-234554 on FormS-3 of our report dated March 3, 2020, relating to the consolidated financial statements of Sierra Oncology, Inc. and subsidiaries (the “Company”) appearing in this Annual Report on Form10-K of the Company for the year ended December 31, 2019.
/s/ Deloitte & Touche LLP |
Grand Rapids, Michigan |
March 3, 2020 |